Passive Antibody Therapies: Progress and Continuing Challenges
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 93 (1) , 5-15
- https://doi.org/10.1006/clim.1999.4768
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- Overcoming obstacles to monoclonal antibody product development and approvalTrends in Biotechnology, 1997
- Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in miceNature Genetics, 1997
- Muromonab CD3Drugs, 1996
- Treatment of chronic cryptosporidial infection with orally administered human serum immune globulinThe Journal of Pediatrics, 1991
- Spontaneous Alteration of Idiotype in a Monoclonal B-Cell LymphomaNew England Journal of Medicine, 1985
- Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype AntibodiesNew England Journal of Medicine, 1985
- Treatment of Life-Threatening Digitalis Intoxication with Digoxin-Specific Fab Antibody FragmentsNew England Journal of Medicine, 1982
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981